J9262
HCPCSInj, omacetaxine mep, 0.01mg
Official HCPCS Level II long descriptor
Injection, omacetaxine mepesuccinate, 0.01 mg
HCPCS Level II code J9262 is maintained by CMS and is active in the current quarterly release.
Short descriptor
Inj, omacetaxine mep, 0.01mg
Added to HCPCS: 2014-01-01
Nearby codes in J9
- J9245Inj melpha hydroch nos 50 mg
- J9246Inj., evomela, 1 mg
- J9248Inj melphalan (hepzato) 1 mg
- J9249Inj, melphalan (apotex) 1 mg
- J9255Inj, methotrexate (accord)
- J9256Inj, nipocalimab-aahu, 3 mg
- J9260Inj methotrexate sodium 50mg
- J9261Nelarabine injection
- J9263Oxaliplatin
- J9264Paclitaxel protein bound
- J9266Pegaspargase injection
- J9267Paclitaxel injection
- J9268Pentostatin injection
- J9269Inj. tagraxofusp-erzs 10 mcg
- J9271Inj pembrolizumab
- J9272Inj, dostarlimab-gxly, 10 mg
Where this code sits
Krasyn AI Coder
Get code suggestions automatically as you type notes. Free for 50 analyses.
Install for Chrome — freeSource
HCPCS Level II July 2026 quarterly update. Centers for Medicare & Medicaid Services (CMS), “July 2026 Alpha-Numeric HCPCS File” (HCPC2026_JUL_ANWEB_06172026.txt). Download the original file from cms.gov. Public domain (US Government work). Descriptors, billable flags and instructional notes on this page are reproduced from that file without modification. Krasyn adds no clinical guidance.